Peripheral intravenous catheter dressing and securement practice is associated with site complications and suboptimal dressing integrity: A secondary analysis of 40,637 catheters

International Journal of Nursing Studies

Volumn 100, Issue , 2019, Pages

  Corley, Amanda ^a,b,c   Ullman, Amanda J ^a,c   Mihala, Gabor ^a   Ray Barruel, Gillian ^a,d   Alexandrou, Evan ^a,e,f   Rickard, Claire M ^a,b,c  

^a GRIFFITH UNIVERSITY   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d Metro South Health   (Australia)

^e LIVERPOOL HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Bandages; Catheterisation, peripheral adverse effects; Phlebitis prevention and control; Polyurethanes therapeutic use; Surgical tape

Indexed keywords

ADVERSE EVENT; BANDAGE; CATHETERIZATION; CROSS-SECTIONAL STUDY; HUMAN; INDWELLING CATHETER;

BANDAGES; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CROSS-SECTIONAL STUDIES; HUMANS;

EID: 85073262403     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2019.103409     Document Type: Article

References (45)

1. Alekseyev S., Byrne M., Carpenter A., et al. Prolonging the life of a patient's IV: an integrative review of intravenous securement devices. Medsurg. Nurs.2012;21:285–92.
2. Alexandrou E., Ray-Barruel G., Carr P.J., et al. International prevalence of the use of peripheral intravenous catheters. J. Hosp. Med.2015;10(8):530–3.
3. Alexandrou E., Ray-Barruel G., Carr P.J., et al. Use of short peripheral intravenous catheters: characteristics, management, and outcomes worldwide. J. Hosp. Med.2018;13.
4. Bolton D.Improving peripheral cannulation practice at an NHS trust. Br. J. Nurs.2010;19:1346, 1348–50.
5. Boyd S., Aggarwal I., Davey P., et al. Peripheral intravenous catheters: the road to quality improvement and safer patient care. J. Hosp. Infect.2011;77:37–41.
6. Cady M., Gross L. I.V.Tape: a potential vector for infection newsletter: Off. J. Anesth. Patient Saf. Found.2011;25.
7. Chopra V., Flanders S.A., Saint S., et al. The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann. Intern. Med.2015;163:S1–40.
8. Frey A.M., Schears G.J.Why are we stuck on tape and suture? A review of catheter securement devices. J. Infus. Nurs.2006;29:34–8.
9. Gabriel J.Vascular access devices: securement and dressings. Nurs. Stand.2010;24:41–6.
10. Galpern D., Guerrero A., Tu A., et al. Effectiveness of a central line bundle campaign on line-associated infections in the intensive care unit. Surgery2008;144:492–5.
11. Gorski L., Hadaway L., Hagle M.E., et al. Infusion therapy standards of practice. J. Infus. Nurs.2016;39:S1–S159.
12. Gunther S.C., Schwebel C., Hamidfar-Roy R., et al. Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the advanced study). Intens. Care Med.2016;42:1753–65.
13. Harris P.N.A., Ashhurst-Smith C., Berenger S.J., et al. Adhesive tape in the health care setting: another high-risk fomite?Med. J. Aust.2012;196.
14. Helm R.E., Klausner J.D., Klemperer J.D., et al. Accepted but unacceptable: peripheral IV catheter failure. J. Infus. Nurs.2015;38:189–203.
15. Hoffmann K.K., Weber D.J., Samsa G.P., et al. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA1992;267:2072–6.
16. Loveday H.P., Wilson J.A., Pratt R.J., et al. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J. Hosp. Infect.2014;86Suppl 1:S1–70.
17. Maki D.G., Ringer M.Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA1987;258:2396–403.
18. Marsh N., Mihala G., Ray-Barruel G., et al. Inter-rater agreement on PIVC-associated phlebitis signs, symptoms and scales. J. Eval. Clin. Pract.2015a;21:893–9.
19. Marsh N., Webster J., Larsen E., et al. Expert versus generalist inserters for peripheral intravenous catheter insertion: a pilot randomised controlled trial. Trials2018a;19:564.
20. Marsh N., Webster J., Larsen E., et al. Observational study of peripheral intravenous catheter outcomes in adult hospitalized patients: a multivariable analysis of peripheral intravenous catheter failure. J. Hosp. Med.2018b;13:83–9.
21. Marsh N., Webster J., Mihala G., et al. Devices and dressings to secure peripheral venous catheters to prevent complications. Cochrane Datab. Syst. Rev.2015b:Cd011070.
22. Mestre G., Berbel C., Tortajada P., et al. Successful multifaceted intervention aimed to reduce short peripheral venous catheter-related adverse events: a quasi-experimental cohort study. Am. J. Infect. Control2013;41:520–6.
23. Miliani K., Taravella R., Thillard D., et al. Peripheral venous catheter-related adverse events: evaluation from a multicentre epidemiological study in France (the Catheval project). PLoS One2017;12:e0168637.
24. Moureau N.L., Trick N., Nifong T., et al. Vessel health and preservation (Part 1): a new evidence-based approach to vascular access selection and management. J. Vasc. Access2012;13:351–6.
25. O'Grady N.P., Alexander M., Burns L.A., et al. Guidelines for the prevention of intravascular catheter-related infections. Am. J. Infect. Control2011;39:S1–34.
26. Ray-Barruel G., Cooke M., Mitchell M., et al. Implementing the I-DECIDED clinical decision-making tool for peripheral intravenous catheter assessment and safe removal: protocol for an interrupted time-series study. BMJ Open2018;8:e021290.
27. Ray-Barruel G., Polit D.F., Murfield J.E., et al. Infusion phlebitis assessment measures: a systematic review. J. Eval. Clin. Pract.2014;20:191–202.
28. Redelmeier D.A., Livesley N.J.Adhesive tape and intravascular-catheter-associated infections. J. Gen. Intern. Med.1999;14:373–5.
29. Rickard C., Marsh N., Webster J., et al. Dressings and securements for the prevention of peripheral intravenous catheter failure (SAVE trial) in adults: a pragmatic, randomised, controlled, superiority trial. Lancet2018;392:419–30.
30. Rickard C.M., Marsh N., Webster J., et al. Securing all intraVenous devices effectively in hospitalised patients – the save trial: study protocol for a multicentre randomised controlled trial. BMJ Open2015;5:e008689.
31. Rickard C.M., McCann D., Munnings J., et al. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med.2010;8:53.
32. Rickard C.M., Webster J., Wallis M.C., et al. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet2012;380:1066–74.
33. Royal College of Nursing. Standards for Infusion Therapy. fourth ed.London: Royal College of Nursing; 2016.
34. Royer T.Improving short peripheral IV outcomes: a clinical trial of two securement methods. J. Vasc. Access2003;8:45–9.
35. Smith B.Peripheral intravenous catheter dwell times: a comparison of 3 securement methods for implementation of a 96-hour scheduled change protocol. J. Infus. Nurs.2006;29:14–7.
36. Talbot D., Massamba V.K.A descriptive review of variable selection methods in four epidemiologic journals: there is still room for improvement. Eur. J. Epidemiol. 2019;34(8):725–30.
37. Timsit J.F., Bouadma L., Ruckly S., et al. Dressing disruption is a major risk factor for catheter-related infections. Crit. Care Med.2012;40:1707–14.
38. Ullman A.J., Cooke M., Rickard C.M.Examining the role of securement and dressing products to prevent central venous access device failure: a narrative review. JAVA2015a;20:99–110.
39. Ullman A.J., Cooke M.L., Mitchell M., et al. Dressings and securement devices for central venous catheters (CVC). Cochrane Datab. Syst. Rev.2015b:Cd010367.
40. United Nations. Regional Groups of Member States. New York, USA: United Nations. Available from: https://www.un.org/Depts/DGACM/RegionalGroups.shtml. Accessed: 21 October 2018.
41. von Elm E., Altman D.G., Egger M., et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int. J. Surg.2014;12:1495–9.
42. Wallis M.C., McGrail M., Webster J., et al. Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial. Infect. Control Hosp. Epidemiol.2014;35:63–8.
43. World Bank. Country and Lending Groups. Washington, DC: The World Bank. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed: 21 October 2018.
44. World Health Organisation. Health Statistics and Information Systems: Definition of Regional Groupings. Geneva, Switzerland: World Health Organisation. Available from: https://www.who.int/healthinfo/global_burden_disease/definition_regions/en/. Accessed: 21 October 2018.
45. Zingg W., Pittet D.Peripheral venous catheters: an under-evaluated problem. Int. J. Antimicrob. Agents2009;34Suppl 4:S38–42.